Ticaflow Tablet 90 mg contains Ticagrelor, an oral antiplatelet agent used to prevent blood clots in patients at risk of cardiovascular events. Ticagrelor belongs to the P2Y12 receptor antagonist class, which works by inhibiting platelet aggregation, reducing the risk of heart attack, stroke, and other thrombotic complications.

Ticaflow Tablet 90 mg is indicated for patients with acute coronary syndrome (ACS), including unstable angina or non-ST elevation myocardial infarction (NSTEMI), and those who have undergone percutaneous coronary intervention (PCI) with stent placement. Its oral formulation allows convenient twice-daily administration for sustained platelet inhibition.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Ticaflow Tablet 90 mg is primarily used for:

• Acute coronary syndrome (ACS): Prevention of thrombotic events in patients with unstable angina or NSTEMI

• Post-percutaneous coronary intervention (PCI): Reduces the risk of stent thrombosis

• Secondary prevention of cardiovascular events: Reduces the risk of heart attack or stroke in high-risk patients

• Patients intolerant to other antiplatelet drugs: Provides an alternative to clopidogrel for effective platelet inhibition

This medication is intended for long-term cardiovascular protection and should be used under strict medical supervision.

Mechanism of Action

Ticagrelor in Ticaflow Tablet works by reversibly inhibiting the P2Y12 receptor on platelets, preventing adenosine diphosphate (ADP)-mediated platelet activation and aggregation:

• Prevents platelet clumping: Reduces formation of thrombi in coronary arteries

• Rapid onset and sustained action: Provides effective antiplatelet activity within hours of administration

• Reversible binding: Allows better control of platelet function compared to irreversible agents

• Synergistic with aspirin: Often prescribed alongside low-dose aspirin to enhance cardiovascular protection

By reducing platelet aggregation, Ticaflow helps prevent clot-related complications such as myocardial infarction, stroke, or stent thrombosis.

Dosage and Administration

• The usual adult dose is 90 mg orally twice daily, with or without food

• Tablets should be swallowed whole with water

• Often prescribed in combination with low-dose aspirin (75–100 mg daily) unless contraindicated

• Do not discontinue therapy without consulting a physician, as abrupt cessation may increase the risk of thrombotic events

• Dose adjustments may be necessary in patients with renal or hepatic impairment

Precautions and Warnings

• Bleeding risk: Ticagrelor increases the risk of bleeding, including gastrointestinal and intracranial hemorrhage; use with caution in patients with bleeding disorders

• Surgery: Inform your surgeon prior to procedures, as Ticagrelor may need to be temporarily discontinued

• Drug interactions: Avoid strong CYP3A4 inhibitors or inducers, as they can affect Ticagrelor levels

• Dyspnea: Some patients may experience mild shortness of breath; consult a physician if severe

• Pregnancy and breastfeeding: Use only if clearly necessary under medical supervision

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Ticaflow Tablet 90 mg is generally well tolerated. Common side effects may include:

• Mild to moderate bleeding, such as nosebleeds, bruising, or gum bleeding

• Shortness of breath (dyspnea) in some patients

• Headache or dizziness

• Gastrointestinal discomfort, including nausea or diarrhea

• Rare: severe bleeding, allergic reactions, or irregular heart rhythm

Seek immediate medical attention if severe bleeding, chest pain, or unexplained bruising occurs.

Storage

Store below 30°C in a cool, dry place, protected from light and moisture. Keep out of reach of children.

Ticaflow Tablet 90 mg provides effective antiplatelet therapy, reducing the risk of cardiovascular events in patients with acute coronary syndrome, post-PCI, or at high risk of thrombotic complications.